Salisbury District Hospital
Salisbury, Wiltshire, SP2 8BJ, United Kingdom
NCT Number: NCT04964635
Functional Electrical Stimulation is an established technique in which small electrical impulses are used to cause a contraction in muscles and thereby enable movement, in people with neurological or musculoskeletal problems who are unable to undertake those movements themselves. People with spinal cord injuries of the neck at C5, C6 and C7 account for 35% of all spinal cord injuries. Despite this, there is only one commercial FES (Functional Electrical Stimulation) based orthosis currently available. Even that has limitations in that it as it has a single size rigid exoskeleton it does not fit all people who could benefit and also due to its rigidity it does not allow people with lower injuries to utilise any remaining tenodesis grip. As a result, it is not widely used within the spinal injured communities. Therefore what is required is a more flexible system that can benefit a larger number of people whilst still being affordable within the constraints of the NHS. A previous INSPIRE funded project, TETRAGRIP I demonstrated that a surface FES system controlled by an inertial sensor, measuring movement of the opposite shoulder, could meet this specification and was successfully tried on two people with tetraplegia. What is now required is a more detailed study in which the principle components of that system are incorporated into a practical device suitable for use at home without clinical supervision. It is therefore proposed to develop and build such a system and to conduct extended home based trials in three people with tetraplegia.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Interventional
Not applicable
Salisbury, Wiltshire, SP2 8BJ, United Kingdom
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This main aim of this whole research project is to evaluate the performance of the TetraGrip II system in improving the upper limb functions in people with C4-C7 tetraplegia i.e. people who have damaged their spinal cord in the neck resulting in loss of function in all four limbs. The Tetragrip system uses a technique called Functional Electrical Stimulation (FES) in which small electrical impulses are used to activate paralysed muscles and hence provide movement. The stimulation is controlled by sensors which measure the movement of the other shoulder and enable the person to regain the use of their hand via stimulating electrodes placed on the skin over the relevant muscles.
The feasibility of using this FES based system in restoring the upper arm functions will be evaluated by clinically trying the device on participants with C4-C7 tetraplegia.
Time frame: Start of study - 30 minutes building up to 60 minutes over a four week period
Test to be completed both with and without the device - exercise daily for 30 minutes, building up to 60 minutes over a four week period
Time frame: At the end of the clinical phase (week 10) - 30 minutes building up to 60 minutes over a four week period
Test to be completed both with and without the device - exercise daily for 30 minutes, building up to 60 minutes over a four week period
Time frame: At the end of the home phase for participants taking the device home (week 18) - 30 minutes building up to 60 minutes over a four week period
Test to be completed both with and without the device - exercise daily for 30 minutes, building up to 60 minutes over a four week period
Time frame: At the start of the study - 30 minutes
Test to be completed both with and without the device
Time frame: At the start of the study - 30 minutes
Test to be completed both with and without the device
Time frame: At the end of the clinical phase (week 10) - 30 minutes
Test to be completed both with and without the device
Time frame: At the end of the clinical phase (week 10) - 30 minutes
Test to be completed both with and without the device
Time frame: At the end of the home phase for participants taking the device home (week 18) - 30 minutes
Test to be completed both with and without the device
Time frame: At the end of the home phase for participants taking the device home (week 18) - 30 minutes
Test to be completed both with and without the device
Time frame: At the start of the study
Test to be completed both with and without the device
Time frame: At the end of the clinical phase (week 10)
Test to be completed both with and without the device
Time frame: At the end of the home phase for participants taking the device home (week 18)
Test to be completed both with and without the device
Bournemouth University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04736849
Central Nervous System Diseases, Nervous System Diseases
Rochester, Minnesota, United States
View Trial DetailsNCT05432999
Central Nervous System Diseases, Muscle Hypertonia
West Orange, New Jersey, United States
View Trial DetailsNCT03482310
Central Nervous System Diseases, Nervous System Diseases
Cleveland, Ohio, United States
View Trial DetailsNCT03495986
Behavior, Central Nervous System Diseases
Miami, Florida, United States
View Trial Details